At creative proteomics, our mission is to accelerate the progress for disease research projects with our unparalleled analytical technology and advanced omics technology platform, to make outstanding contributions to disease diagnosis, treatment, and prognosis. This is why we are trusted by the world's leading biopharmaceutical companies and research institutions to advance their drug discovery, preclinical and clinical research projects. We have extensive experience in oncology, immunology and immune-mediated inflammatory diseases. Make full use of the infinite possibilities of scientific innovation and more than 50 diseases can be detected in one platform.
Accelerate your oncology program using our comprehensive suite of quantitative proteomics services for large cohort clinical samples.
Advance inflammatory diseases research with our integrated quantitative proteomics for Alzheimer's disease, Parkinson's, Autism, Chronic pain, etc.
Discover of unique high throughput quantitative proteomics platform for Neurological disorders enables large-scale proteomic or phosphoproteomic analysis of brain tissue or cerebrospinal fluid.
Next-generation proteomics has increasing use in endocrine and metabolic diseases, including pituitary, thyroid, bone metabolic disorders, diabetes, and obesity.
Reveal a deeper understanding of the underlying biology and provide actionable knowledge to accelerate and de-risk your research in rare diseases.
4D Proteomics with Data-Independent Acquisition (DIA)
Online Inquiry
×Specializing in proteomics, Creative Proteomics offers cutting-edge protein analysis services. Our distinctive approach revolves around harnessing the power of DIA technology, enabling us to deliver precise and comprehensive insights that drive advancements in research and industry.